InvestorsHub Logo

A_Good_Day_2

12/03/16 9:13 PM

#81892 RE: drv17 #81891

Interesting... the original 2a trial mentioned other drugs in the "purpose" section.

From clinicaltrials.gov:

"Purpose
...and to explore the relationship of ANAVEX2-73 as add-on therapy to AD standard of care."

Sounds like they did drop the idea of dual therapy...